These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 25834048)

  • 1. Definition of a molecular pathway mediating α-synuclein neurotoxicity.
    Burré J; Sharma M; Südhof TC
    J Neurosci; 2015 Apr; 35(13):5221-32. PubMed ID: 25834048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation.
    Burré J; Sharma M; Südhof TC
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4274-83. PubMed ID: 25246573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
    Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
    Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Sporadic Parkinson Disease Associated Mutations A18T and A29S in Enhanced α-Synuclein Fibrillation and Cytotoxicity.
    Kumar S; Jangir DK; Kumar R; Kumari M; Bhavesh NS; Maiti TK
    ACS Chem Neurosci; 2018 Feb; 9(2):230-240. PubMed ID: 28841377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities.
    Burré J; Sharma M; Südhof TC
    J Neurosci; 2012 Oct; 32(43):15227-42. PubMed ID: 23100443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
    Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
    Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral mimetic priming enhances α-synuclein-induced degeneration: Implications for Parkinson's disease.
    Olsen LK; Cairns AG; Ådén J; Moriarty N; Cabre S; Alamilla VR; Almqvist F; Dowd E; McKernan DP
    Brain Behav Immun; 2019 Aug; 80():525-535. PubMed ID: 31029796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.
    St Martin JL; Klucken J; Outeiro TF; Nguyen P; Keller-McGandy C; Cantuti-Castelvetri I; Grammatopoulos TN; Standaert DG; Hyman BT; McLean PJ
    J Neurochem; 2007 Mar; 100(6):1449-57. PubMed ID: 17241127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice.
    Caló L; Hidari E; Wegrzynowicz M; Dalley JW; Schneider BL; Podgajna M; Anichtchik O; Carlson E; Klenerman D; Spillantini MG
    Brain; 2021 Jul; 144(6):1661-1669. PubMed ID: 33760024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.
    Jarvela TS; Lam HA; Helwig M; Lorenzen N; Otzen DE; McLean PJ; Maidment NT; Lindberg I
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4708-15. PubMed ID: 27457957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
    Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA
    Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease.
    Arawaka S; Fukushima S; Sato H; Sasaki A; Koga K; Koyama S; Kato T
    PLoS One; 2014; 9(2):e89076. PubMed ID: 24586512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J; Uversky VN; Fink AL
    Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity.
    Wu M; Su H; Zhao M
    Neurotox Res; 2021 Jun; 39(3):1007-1021. PubMed ID: 33555547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease.
    Basu S; Je G; Kim YS
    Exp Mol Med; 2015 Aug; 47(8):e179. PubMed ID: 26315598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration.
    Xilouri M; Brekk OR; Landeck N; Pitychoutis PM; Papasilekas T; Papadopoulou-Daifoti Z; Kirik D; Stefanis L
    Brain; 2013 Jul; 136(Pt 7):2130-46. PubMed ID: 23757764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.